Latest Reports
Metabolic Biomarkers Market - Strategic Insights and Forecasts (2026-2035)
The metabolic biomarkers market supports the identification, monitoring, and characterization of biological processes associated with metabolism and functions as a critical component of precision medicine, disease diagnosis, and therapeutic...
Inflammation-related Biomarkers Market - Strategic Insights and Forecasts (2026-2035)
The inflammation-related biomarkers market supports the detection, characterization, monitoring, and therapeutic assessment of inflammatory processes across a broad range of diseases including autoimmune disorders, cancer, cardiovascular di...
Immune Biomarkers Market - Strategic Insights and Forecasts (2026-2035)
The immune biomarkers market supports the identification, measurement, and interpretation of immune system activity across disease diagnosis, treatment selection, therapeutic monitoring, and drug development. The market functions as a found...
Companion Diagnostics Clinical Development Market - Strategic Insights and Forecasts (2026-2035)
The Companion Diagnostics Clinical Development Market supports the identification, validation, and regulatory qualification of biomarkers that guide patient selection for targeted therapies. The market functions as a critical component of p...
KRAS Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The KRAS Companion Diagnostics Market supports the identification of patients eligible for KRAS-targeted therapies through molecular testing technologies that detect clinically actionable KRAS mutations. The market functions as a foundation...
Hospital-Acquired Infection Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The Hospital-Acquired Infection (HAI) Diagnostics Market supports the identification of infections acquired during healthcare delivery through microbiology, molecular diagnostics, immunoassays, and rapid testing platforms. The market serves...
HER2 Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The HER2 Companion Diagnostics Market supports the identification of patients eligible for HER2-targeted therapies across multiple oncology indications. The market functions as a critical component of precision medicine because therapeutic ...
Hematology Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The Hematology Companion Diagnostics Market supports precision treatment selection across hematologic malignancies by identifying biomarkers that predict therapeutic response, resistance patterns, and disease progression. The market functio...
EGFR Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The EGFR Companion Diagnostics Market supports the identification of patients eligible for EGFR-targeted therapies across multiple oncology indications, particularly in non-small cell lung cancer (NSCLC) and other solid tumors. The market s...
Companion Diagnostics Software Market - Strategic Insights and Forecasts (2026-2035)
Companion diagnostics software enables the interpretation, management, and clinical application of molecular and genomic data used to guide targeted therapeutic decisions. The market functions as a digital infrastructure layer connecting se...
Companion Diagnostics Services Market - Strategic Insights and Forecasts (2026-2035)
The Companion Diagnostics Services Market supports pharmaceutical and biotechnology companies in developing, validating, and commercializing diagnostic assays that identify patients most likely to benefit from targeted therapies. These serv...
BRAF Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The BRAF Companion Diagnostics Market supports the identification of patients eligible for targeted therapies through molecular testing that detects clinically actionable BRAF mutations. The market functions as a critical component of preci...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.